Chai Discovery is a pioneering company leveraging artificial intelligence to enhance drug discovery and address diseases. By integrating AI technologies, the company aims to streamline the traditionally lengthy and costly drug development process, offering innovative solutions in the pharmaceutical industry.
Estimated Valuation
Powered by
Leadership & Board
Key Executives
- CEO
- Joshua Meier
- Founder
- Jack Dent
- Founder
- Matthew McPartlon
- Founder
- Jacques Boitreaud
- Current Number of Employees
- 45
- Current LinkedIn Followers
- 24,771
Latest Estimated Valuation
- Estimated Valuation
- $4B
- Total Amount Raised
- $600M
- Total Funding Rounds
- 3
- Latest Funding Amount
- $400M
- Latest Funding Round
- Series C
- Post-Money Valuation
- $4B
Employee Trend
Chai Discovery had 45 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
45Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Chai Discovery had 24,771 followers as of October 26, 2026. The number of followers increased by 316 (1.29%) week-over-week.
24,771Latest Followers Count
316(1.29%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 17, 2026 | Series C | $400.00M | $3.80B |
| Dec 15, 2025 | Series B | $130.00M | $1.30B |
| Sep 05, 2025 | Investment | $70.00M | $550.00M |
Investors
| Investor Name | Funding Round |
|---|---|
| Index Ventures | Series C |
| Kleiner Perkins | Series C |
| Sequoia Capital | Series C |
| Dimension | Series C |
| Bain Capital Ventures | Series C |
| Battery Ventures | Series C |
| Baillie Gifford | Series C |
| BDT & MSD | Series C |
Similar Companies
A snapshot of private companies similar to Chai Discovery, helping you discover and navigate related company profiles.
Related News and Analysis
